<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
	"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
	
	<head>
		<title>Publications - Jain PharmaBiotech</title>
		<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
		<link rel="stylesheet" href="../base.css" type="text/css" />
		<script src="http://www.google-analytics.com/urchin.js" type="text/javascript"> </script>
		<script type="text/javascript">
			_uacct = "UA-112726-1";
			urchinTracker();
		</script>
	</head>
	
	<body>
		
		<div id="navigation">
			<a href="/">Home</a>
			<a href="/reports/">Reports</a>
			<a class="current" href="/publications/">Publications</a>
			<a href="/lectures/">Lectures</a>
			<a href="/contact.htm">Contact</a>
		</div>
		
		<div id="content">
		
			<h1>Publications</h1>
			
			<ul>
				<li><a href="#1">Scientific Papers and Reviews</a></li>
				<li><a href="#2">Contributions to Neurobase</a></li>
				<li><a href="#3">Books</a></li>
				<li><a href="#4">Reports</a></li>
			</ul>
			
			<h2><a name="1">Journal articles and chapters in books</a></h2>
			
			<h3>Neurosurgery</h3>
			
			<ol>
				<li>With Prof. D. Parkinson: Hydrocephalus-A shunt between ventricles and Stenson's Duct. Canad J Surg 4:183-185,1961.</li>
				<li>With Prof. D. Parkinson: Saccular Aneurysm of the Ophthalmic Artery. Canad J Surg 4:229-232,1961.</li>
				<li>Mechanism of Rupture of Intracranial Saccular Aneurysms. Surgery 54:347-350,1963</li>
				<li>Partial Carotid Occlusion as Treatment of Intracranial Internal Carotid Aneurysms. Canad Med Assoc J 88:245-251,1963.</li>
				<li>With Dr. R. Ojemann: Carotid Blood Flow in Paget's Disease of the skull-A study with electromagnetic flowmeter. J Neurosurg 20:471-473,1963.</li>
				<li>Aberrant Roots of the Abducent nerve. J Neurosurg 21:349-351.</li>
				<li>Some Observations on the Anatomy of the Middle Cerebral Artery. Canad J Surg 7:134-137,1964.</li>
				<li>Surgery of Intracranial Berry Aneurysms. Canad J Surg 8:172-187,1965.</li>
				<li>Intraventricular Cavernous Hemangioma of the Lateral Ventricle. J Neurosurg 24:762-764,1966.</li>
				<li>Headache in relation to intracranial aneurysm. Headache 7:122-126,1967.</li>
				<li>Congenital anomaly of the cervical spine simulating fracture dislocation. J Canad Assoc Radiol 19:329,1967.</li>
				<li>Chronic benign thrombosis of the superior sagittal sinus. J Canad Assoc Radiol 20:39,1968.</li>
				<li>With Dr. Posner: An unusual case of severe burns, meningitis, obstructive hydrocephalus and neuroblastoma in a child under age two. Clin Ped 7:283-288,1968.</li>
				<li>Total visualization of the intracranial arterial circulation following unilateral carotid angiography in a patient with ruptured posterior cerebral aneurysm. Am J Roent 104:83-85,1968.</li>
				<li>Recurrence of existed cavernous hemangioma in the opposite cerebral hemisphere. J Neurosurg 33:453-456,1968.</li>
				<li>Saccular aneurysm of the ophthalmic artery. Am J Ophthalmol 69:997-998,1970.</li>
				<li>Doctor's status in the community. Canadian Doctor, Feb.1970, p.66.</li>
				<li>Diagnosis of extradural hematoma by brain scan. Canad M Assoc J 107:218-219,1972.</li>
				<li>Glimpses of neurosurgery in the People's Republic of China. International Surgery 57:155-158,1972.</li>
				<li>Aneurysms of the vertebral-basilar system. Proceedings of the 3rd Canadian Congress of Neurological Sciences, 1968. Book of Abstracts, p24.</li>
				<li>Glimpses of Chinese Medicine. Canad Med Assoc J 106:46-50,1972.</li>
				<li>Reoperative Surgery for Lumbar Disc Protrusions. International Surgery 59:106,1974.</li>
				<li>Surgery of Intact Intracranial Aneurysms. J Neurosurg 40:495-498,1974.</li>
				<li>Surgery of Anterior Communicating Aneurysms. Surg Neurol 2:31-33,1974.</li>
				<li>Familial Intracranial Aneurysms. Acta Neurochir 30:129-137,1974.</li>
				<li>Sciatica and herpes simplex. J Neurosurg 41:518,1974.</li>
				<li>Use of Diazepam in cerebral angiography. Canadian J Neurol Sci 1:141-142,1974.</li>
				<li>Anterior approach to the cervical spine. Canad Med Assoc Journal 111:49-50,1974.</li>
				<li>Evaluation of a surgeon's competence. Modern Medicine of Canada 29:7-8,1974.</li>
				<li>Nerve root scarring as a complication of lumbar disc surgery. Neurochirurgia 17:185-192,1974.</li>
				<li>Acupuncture and the neurosurgeon. Am J Acupuncture 2:164-166,1974.</li>
				<li>Reoperative surgery on patients with lumber disc surgery. International Surgery 60:29-32,1975.</li>
				<li>Neurosurgery at SCT Medical Center, India. Kerala Medical Journal 16:67-69,1976.</li>
				<li>Management of neurosurgical emergencies. Kerala Medical Journal 16:67-69,1976.</li>
				<li>Are your peers what they appear to be? Canadian Doctor, August 1975,p.58-60.</li>
				<li>With Prof. MG Yasargil: Arteriovenous malformations of the splenium of the corpus callosum--microsurgical treatment. Surg Neurol 5:5-14,1976.</li>
				<li>With Prof. MG Yasargil: Arteriovenous malformations of the anterior and middle portions of the corpus callosum--microsurgical treatment. Surg Neurol 5:67-80,1976.</li>
				<li>With Prof. MG Yasargil: Frontolateral pterion approach to the basilar bifurcation Aneurysms. Surg Neurol 6:83-91,1976.</li>
				<li>With Prof. MG Yasargil: Arteriovenous malformations of the vein of Galen. Microsurgical treatment. Surg Neurol 6:195-200,1976.</li>
				<li>With Prof. MG Yasargil: Anatomy of the subarachnoid cisterns of the brain. J Neurosurg 44:298-302,1976.</li>
				<li>With Prof. K-H. Holbach: Differentiation between reversible and irreversible post-stroke changes in the brain tissue and its relevance to cerebrovascular surgery. Surg Neurol 7:324-331,1977.</li>
				<li>Practice of Medicine in Shiraz (Iran). World Medicine, 8 Feb 1978,p.19-22.</li>
				<li>Repair of small blood vessels with Nd:YAG laser. Surgery 85:684-688,1979.</li>
				<li>Microvascular repair with Nd:YAG laser. Acta Neurochir Supp 28:260-262,1979.</li>
				<li>Sutureless microvascular anastomosis using Nd:YAG laser. J Microsurgery 1:436-439,1980.</li>
				<li>Surgical treatment of unruptured intracranial aneurysms. Acta Neurochir 66:187-194,1982.</li>
				<li>Photocoagulation of cerebral arteriovenous malformations and arterial aneurysms with Nd:YAG laser. Neurosurgery 13:374,1982.</li>
				<li>Pitfalls in the diagnosis of intracranial aneurysms. American Family Physician 27:139-144,1983.</li>
				<li>Lasers in neurosurgery--A review. Laser in Surg &amp; Med 2:217-230,1983.</li>
				<li>Sutureless end-to-side microvascular anastomosis with Nd:YAG laser. Vasc. Surg 17:240-243, 1983.</li>
				<li>Nahtlose End-zu-Seite mikrovaskulare Anastomose mit Nd:YAG laser (German). In Staeler G, Hoffstetter A(eds): Verhandlungsbericht Deutsche Gesellschaft f�ermedizin, W. Zuckerschwerdt Verlag, M�, 1983:69-72.</li>
				<li>Der Laser in der Neurochirurgie. Fortschr Med 101:1930-1934,1983.</li>
				<li>Nd:YAG Laser in Microneurosurgery. In, Jaffe SN (ed): Nd:YAG Laser in Medicine and Surgery. Elsevier Publishing Company, New York,1983:131-140.</li>
				<li>With Prof. H. Wassmann: Cerebral protection during carotid endarterectomy. Acta Neurochir 71:99-108,1984.</li>
				<li>Role of Laser in Microvascular Surgery. In Proceedings of ICALEO'83, Vol 37. Laser Institute of America, Toledo, Ohio, 1984:90-93.</li>
				<li>Current status of laser application in neurosurgery. IEEE Journal of Quantum Electronics 20:1401-1406,1984.</li>
				<li>Sutureless extra-intracranial anastomosis using Nd:YAG laser-clinical application. Lancet ii:816-817,1984.</li>
				<li>Lasers in neurological surgery. J Neurosurg 60:872,1984.</li>
				<li>Laser surgery. JAMA 251:2349,1984.</li>
				<li>Complications of Nd:YAG laser application in neurosurgery. Neurosurgery 16:759-762, 1985.</li>
				<li>Incision of the brain with varipulse carbon dioxide laser. Neurosurgery 18:762-765, 1986.</li>
				<li>With B. Fischer: Improvement of information processing ability of the brain and of the fluid intelligence by brain jogging. Geriatrics, pregeriatrics and rehabilitation 2(2):42-54,1986.</li>
				<li>CO2 laser provides safe, complete excision of difficult brain tumors. Laser Practice Report 3(1):1s-2s,1987.</li>
				<li>Sutureless Microvascular Anastomosis with Nd:YAG Laser. J Neurosurg 68:829,1988.</li>
				<li>Anastomosis extra-intracranial sin sutura utilizando el laser Nd:YAG. Experiencia clinica (Spanish). Investigacion Y Clinica Laser 4:50-53,1987.</li>
				<li>Quackery and Health Frauds against the Elderly. Geriatric Pregeriatrics and Rehabilitation 3:106-108,1987.</li>
				<li>Mentaltraining: Grundlegende Prinzipien und Anwendungen (in German). Natur- und Ganzheits Medizin 2:45-48,1988.</li>
				<li>With B. Fischer: Diagnostic steps of dementia in the commentary by C.G. Gottfries. Alzheimer Dis Assoc Disord 1989 Winter;3(4):228-30.</li>
			</ol>
			
			<h3>Hyperbaric medicine</h3>
			
			<ol start="69">
				<li>Jain KK, Fischer B: New Aspects of the use of Hyperbaric Oxygenation for Rehabilitation of Stroke Patients. Geriatrics and Rehabilitation 1:45-46,1988.</li>
				<li>With B. Fischer: Clinical, biochemical and mental changes during hyperbaric oxygen therapy. Proceedings of the First Swiss Symposium on Hyperbaric Medicine, Basel, 1986. pp.256-278.</li>
				<li>With B. Fischer: Effect of Hyperbaric Oxygen Therapy on Migraine Headaches. XIII Annual Meeting of EUBS on Diving and Hyperbaric Medicine, Palermo, Italy, September 9-12, 1987(Abstract).</li>
				<li>With B. Fischer: Blood lactate and ammonia levels during exercise under hyperbaric oxygenation. Proc XIII Annual EUBS Meeting, Palermo Italy. Marroni A and Oriani G (eds). 1987:123-125.</li>
				<li>With B. Fischer: Role of Hyperbaric Oxygen Therapy in Geriatrics. In Abstracts, Romanian Journal of Geriatrics and Gerontology, Supplement to No.1, Vol 9, 1988. Bucharest, Romania.</li>
				<li>Exercise Therapy for Stroke Patients under Hyperbaric Oxygenation Presented at the 7th International Symposium ADAPTED PHYSICAL ACTIVITY. Berlin, 21-24 June, 1989. Published in volume of abstracts, page 107-108.</li>
				<li>Effect of Hyperbaric Oxygen on spasticity in stroke patients. Journal of Hyperbaric Medicine 4:55-61,1989.</li>
				<li>Effectiveness of Hyperbaric oxygen in stroke rehabilitation. In Bakker DJ, Schmutz J (eds): Proceedings of the Second Swiss Symposium on Hyperbaric Medicine, Basel, Foundation for Hyperbaric Medicine, 1990, pp.341-345.</li>
				<li>With Dr. S. Gottlieb: Hyperbaric Therapy -- A critical evaluation. Fort Lauderdale, Florida. American College of Hyperbaric Medicine, 1990:1-186.</li>
				<li>Hyperbaric oxygen and combat casualty care (letter). Military Medicine 155:A10,1990.</li>
				<li>High pressure neurological syndrome (HPNS). Acta Neurologica Scandinavica 1994;90:45-50.</li>
				<li>Hyperbaric oxygen therapy. N Engl J Med 1996;335:1684.</li>
				<li>Hyperbaric oxygen therapy in acute stroke. Stroke 2003 September;34:e153.</li>
			</ol>
			
			<h3>Biopharmaceutical topics</h3>
			
			<ol start="82">
				<li>Association of low circulating thyroid hormones with carbamazepine therapy. J Pharmaceutical Med 1;239-253:1991</li>
				<li>Lupus erythematosus like syndromes associated with carbamazepine therapy. Drug Safety 6;350-360:1991</li>
				<li>Investigation and management of loss of efficacy of an antiepileptic medication using carbamazepine as an example. J Roy Soc Med 1993;86:133-136.</li>
				<li>With Dr. J. Bem. Classification of causality of adverse drug reactions. J Pharmaceutical Med 2;101-107:1993.</li>
				<li>Drug-induced cutaneous vasculitis. Adv Drug React &amp; Toxicol Rev 12:263-276,1993.</li>
				<li>Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J Am Acad Dermatol 1994;31:213-215.</li>
				<li>A short practical method for triage of adverse drug reactions. Drug Information Journal 1995;29:339-342.</li>
				<li>Swiss embrace complementary medicine. Nature Medicine 1995;1:107.</li>
				<li>Sweet's syndrome associated with granulocyte colony-stimulating factor. CUTIS 1996;57:107-110.</li>
				<li>Molecular genetic profiling for diagnostics and clinical trials. Drug Discovery Today 1997;2:310-311.</li>
				<li>Strategies and technologies for drug delivery systems. Trends in Pharmacological Sciences 1998;19:155-157.</li>
				<li>Pharmacotherapy of chronic venous insufficiency: a critical review. Journal of Drug Assessment 1998;1:269-288.</li>
				<li>Effect of oxerutins on venous endothelium: its relevance to pharmacotherapy of CVI. International Angiology 1999;18 (Suppl 1):6-11.</li>
				<li>Functional Genomics: strategies and enabling technologies for target and drug discovery. Drug Discovery Today 1999;4:50-53.</li>
				<li>Advances in Molecular Labels, Signaling and Detection: enhancing sensitivity, accuracy and speed. Drug Discovery Today 1999;4: 346-349.</li>
				<li>Emerging therapeutic targets for glioblastoma multiforme. Emerging Therapeutic Targets 1999;3(4):613-627.</li>
				<li>Nicaraven for the treatment of cerebral vasospasm in subarachnoid haemorrhage. Exp Opin Invest Drugs 2000;9:859-870.</li>
				<li>Neuroprotective therapy for stroke. Exp Opin Invest Drugs 2000;9:695-711.</li>
				<li>An assessment of rufinamide as an antiepileptic in comparison with other drugs in clinical development. Exp Opin Invest Drugs 2000;9:829-840.</li>
				<li>Biotechnological applications of lab-chips and microarrays. Trends in Biotechnology 2000;18:278-280.</li>
				<li>An evaluation of mitoxantrone for the management of multiple sclerosis. Exp Opin Invest Drugs 2000;9:1139-1149.</li>
				<li>Applications of biochip and microarrays systems in pharmacogenomics. Pharmacogenomics 2000;1(3):289-307.</li>
				<li>An evaluation of levetirecetam in the management of epilepsy. Exp Opin Invest Drugs 2000;9:1611-1624.</li>
				<li>An evaluation of memantine in the management of dementia. Exp Opin Invest Drugs 2000;9:1397-1406.</li>
				<li>An evaluation of zonisamide in the management of epilepsy. Exp Opin Invest Drugs 2000;1:1245-1260.</li>
				<li>Transforming innovation and commercialization in drug discovery. Drug Discovery Today. 2000;5:318-320.</li>
				<li>A guide to drug evaluation for chronic pain. Emerging Drugs: The Prospect for Improved Medicines. 2000;1:241-257.</li>
				<li>An evaluation of intrathecal ziconotide for the treatment of chronic pain. Exp Opin Invest Drugs 2000;9:2403-2410.</li>
				<li>An evaluation of iloperidone for the treatment of schizophrenia. Exp Opin Invest Drugs 2000;9:2935-2943.</li>
				<li>Evaluation of intravenous parecoxib for the relief of acute postsurgical pain. Exp Opin Invest Drugs 2000;9:2717-2723.</li>
				<li>Applications of proteomics in oncology. Pharmacogenomics 2000;1:385-393.</li>
				<li>Bacteria as anticancer agents. Expert Opinions in Biological Therapies 2001;1:291-300.</li>
				<li>CHI's 3rd Annual Conference: Lab-on-Chip and Microarrays, 22-24 January 2001, Z� Switzerland. Pharmacogenomics 2001;2:73-77.</li>
				<li>Genomics for business. Drug Discovery Today 2001;6:131-132.</li>
				<li>With Eric Jain: <a href="/publications/20010501.pdf">Integrated Bioinformatics - high-throughput interpretation of pathways and biology.</a> Trends in Biotechnology 2001;19:157-158.</li>
				<li>More clinical input required for R&amp;D decision-making? Drug Discovery Today 2001;6:175-176.</li>
				<li><a href="/publications/20010507.htm">Proteomics: new technologies and their applications.</a> Drug Discovery Today 2001, 6:457-459.</li>
				<li>Applied neurogenomics. Pharmacogenomics 2001;2:143-153.</li>
				<li>In the pipeline: new antipsychotics. Clinical Researcher 2001;5:12-18.</li>
				<li><a href="/publications/20010801.pdf">Proteomics: delivering new routes to drug discovery - part I.</a> Drug Discovery Today 2001 Aug 1;6:772-774.</li>
				<li><a href="/publications/20010802.pdf">Proteomics: delivering new routes to drug discovery - part II.</a> Drug Discovery Today 2001 Aug 15;6: 829-832.</li>
				<li>Will neurogenomics revolutionalize neurotherapeutics? (editorial). Expert Rev Neurotherapeutics 1:89-91, 2001.</li>
				<li><a href="/publications/20011019.pdf">Biochips for gene spotting.</a> Science 294:621-623, 2001.</li>
				<li>Post-genomic applications of lab-on-a-chip and microarrays. Trends in Biotechnology 2002;5:184-185.</li>
				<li>Application of Laser Capture Microdissection to Proteomics. Methods in Enzymology 2002;356:157-167.</li>
				<li>Recent advances in oncoproteomics. Current Opinion in Molecular Therapeutics. 2002;4:203-209.</li>
				<li>Using proteomics to identify targets and leads. Trends in Biotechnology 2002;20:319-320.</li>
				<li>From Molecular diagnostics to personalized medicine. Expert Rev Med Diagn 2002;2:89-91.</li>
				<li>The role of protein chip technology in molecular diagnostics. IVD Technology 2002 July/August;8:49-56.</li>
				<li>Proteomics 2002. Drug Discovery Today 2002;7:900-902.</li>
				<li>Role of proteomics in diagnosis of cancer. Techn Cancer Res &amp; Dev 2002;1:281-286.</li>
				<li>Proteomics-based anticancer drug discovery and development. Techn Cancer Res &amp; Dev 2002;1:231-236.</li>
				<li>Oncoproteomic State-of-the-Art (editorial). Techn Cancer Res &amp; Dev 2002;1:219-220.</li>
				<li>Role of Neuroproteomics in CNS Drug Discovery. Targets 2002;1:95-101.</li>
				<li>The Neurobiology and Neuropharmacology of Alzheimer's Disease: Roads to Treatment Strategies. ASPET-Ray Fuller Symposium, 20-24 April 2002, New Orleans, LA, USA. ID Weekly Highlights, Current Drugs Ltd, May 2002.</li>
				<li>Angiogenesis in brain tumors. In, Black PM &amp; Loeffler J (eds) Cancer of the Nervous System, 2nd ed. Lippincott, Williams &amp; Wilkins, Philadelphia, 2005:761-778.</li>
				<li>Stem Cell Technologies in Regenerative Medicine. Exp Opin Biol Ther  2002;2:771-773</li>
				<li>Ethical and regulatory aspects of embryonic stem cell research. Exp Opin Biol Ther  2002;2:819-826</li>
				<li>Current trends in molecular diagnostics. Medical Device Technology 2002;13:14-18</li>
				<li>Personalised medicine. Curr Opinion Mol Ther 2002;4:548-558</li>
				<li>Nanodiagnostics:application of nanotechnology in molecular diagnostics. Expert Rev Mol Diagn 2003;4:153-161</li>
				<li>Lab-on-a-Chip and Microarrays:Discovery and Development. Pharmacogenomics 2003;4:123-125</li>
				<li>Current trends in molecular nanosensors. Medical Device Technology 2003;14:10-15</li>
				<li>Proteomics and Drug Discovery, Chapter 20 in "Proteomics in Nephrology", Contributions to Nephrology,Vol 141,Karger, 2003:308-327</li>
				<li>Proteomics and Protein Arrays Europa: IIR Conference, Copenhagen, 16-18 June 2003. Pharmacogenomics 2003 July;4:383-385</li>
				<li>Proteomics for Drug Target and Biomarker Identification: IBC Conference, Basel, 30 June-2 July 2003. Targets 2003 October;2:189-190</li>
				<li>Information on commercial aspects of pharmacogenomics. Pharmacogenomics 2003;4:801-803</li>
				<li>Modulators of nicotinic acetylcholine receptors as analgesics. Curr Opinion Invest Drugs 2004;5:76-81.</li>
				<li>Application of Proteomic Technologies for Drug Discovery, Chapter 9 in, Hondermark H (ed) Proteomics: Biomedical and Pharmaceutical Applications, Kluwer Academic, The Netherlands, 2004:201-228</li>
				<li>Proteomics-based Anticancer Drug Discovery. In, LaRochelle WJ (ed) The Oncogenomics Handbook. The Humana Press, Totowa, USA, 2005:123-134.</li>
				<li>Applications of Biochips: from Diagnostics to Personalized Medicine. Current Opinion in Drug Discovery and Development 2004;7:285-9.</li>
				<li>RNAi and siRNA in Target Validation. Drug Discovery Today 2004;9:307-9.</li>
				<li>RNAi and siRNA - BioTrends Conference 2004. Pharmacogenomics 2004;5:5:331-6.</li>
				<li>Role of Pharmacoproteomics in the Development of Personalized Medicine. Pharmacogenomics 2004;5:239-42.</li>
				<li>Current Status of Fluorescent In Situ Hybridization. Medical Device Technology  2004 May:14-17.</li>
				<li>Role of oncoproteomics in the personalized management of cancer. Expert Rev Proteomics 2004;1:89-95.</li>
				<li>Nanotechnology-based Lab-on-a-Chip Devices. In, Encyclopedia of Diagnostic Genomics and Proteomics, Marcel Dekkar Inc, New York, 2005:891-895.</li>
				<li>Personalized Medicine. In, Encyclopedia of Diagnostic Genomics and Proteomics, Marcel Dekkar Inc, New York, 2005:994-999.</li>
				<li>Proteomic Technologies for Cancer Target Validation. Drug Discovery Today-Technologies. 2004;1:75-78.</li>
				<li>Ethical and regulatory aspects of embryonic stem cell research. Expert Opin Biol Ther 2005;5:153-162.</li>
				<li>Nanotechnology in Clinical Laboratory Diagnostics. Clinica Chimica Acta 2005;358:37-54.</li>
				<li>Personalised Medicine for Cancer - From Drug Development into Clinical Practice. Exp Opinion Pharmacotherapy 2005;6:1463-76).</li>
				<li>Nanotechnology-based Drug Delivery for Cancer. Technology in Cancer Research &amp; Treatment 2005;4:407-416.</li>
				<li>Drug Delivery for Cancer (editorial). Technology in Cancer Research &amp; Treatment 2005;4:311-314.</li>
				<li>The role of nanobiotechnology in drug discovery. Drug Discovery Today 2005;10:1435-1442.</li>
				<li>Applications of AmpliChip CYP450. Molecular Diagnosis 2005;9:119-127.</li>
				<li>Conference Report on Personalized Medicine, IBC 14 Sep 2005, Boston MA. Personalized Medicine 2005 November;2:287-290.</li>
				<li>Conference Report on Molecular Diagnostics, IBC 13 Sep 2005, Boston MA. Exp Rev Mol Diagn 2005:847-9.</li>
				<li>Role of Nanobiotechnology in Developing Personalized Medicine for Cancer. TCRT 2005;4:645-650.</li>
				<li>Applications and commercial potential of RNAi. Conference report RNAi Europe 2005. IDrugs 2005 December;8:982-983.</li>
				<li>Personalized Neurology. Personalized Medicine 2005;2:15-21.</li>
				<li>What can transcranial magnetic stimulation offer general neurology practice? Practical Neurology 2005;4:34-40.</li>
				<li>Nanoparticles as targeting ligands. Trends Biotechnol 2006;24:143-5.</li>
				<li>Future prospects for the cure of brain cancer (editorial). TCRT 2006;5:183-184.</li>
				<li>Role of nanotechnology in developing new therapies for diseases of the nervous system (editorial). Nanomedicine 2006;1:9-12.</li>
				<li>A Critical Review of the Royal Society's Report on Personalized Medicine (editorial). Drug Discovery Today 2006;11:573-575.</li>
				<li>Jain KK. Gene Therapy, in Pharmacology, edited by Majewski H, in Encyclopedia of Life Support Systems (EOLSS), Developed under the auspices of the UNESCO. <a href="http://www.eolss.net/">Eolss Publishers</a>, Oxford, UK. </li>
				<li>Commercial potential of RNAi. Mol BioSystems 2006:2:523-526.</li>
				<li>Impact of Nanotechnology on Healthcare. Nanotechnology Law &amp; Business 2006;3(4):411-418.</li>
				<li>Challenges of developing personalized medicines. Current Opinion in Molecular Therapeutics 2006;8:487-492.</li>	
				<li>Integrative Omics, Pharmacoproteomics, and Human Body Fluids. In, Thongboonkerd V (ed) Proteomics of Human Body Fluids: Principles, Methods, and Applications. <a href="http://www.humanapress.com/index.php?option=com_bookdetails&task=reviewtoc&product_code=1-58829-657-1&category=books/">Humana Press</a>, Totowa, NJ, 2007:pp 175-192.</li>
				<li>Jain KK. Role of Nanobiotechnology in the Development of Nanomedicine. In, Thassu D, et al (eds) Nanoparticulate Drug Delivery Systems. Informa Healthcare, London, 2007:pp 173-183.</li>
				<li>Jain KK. Oncoproteomics for Personalized Management of Cancer. In, Daoud SS (ed) Proteomics in Cancer Therapy. Humana Press, Totowa, NJ, 2008:81-99.</li>
				<li>Jain KK. Nanomedicine. In, Shoseyov O &amp; Levy I (eds) NanoBioTechnology: BioInspired device and materials of the future. Humana Press, Totowa, NJ, 2008:303-327.</li>
				<li>Use of nanoparticles for drug delivery in glioblastoma multiforme. Expert Review of Neurotherapeutics 2007;7:363-372.</li>
				<li>Nanobiotechnology-based drug delivery to the central nervous system. Neurodegenerative Dis 2007;4:287-291.</li>
			<li>Stability and delivery of RNA via the gastrointestinal tract. Curr Drug Delivery 2008;5:27-31.</li>
			<li>Role of nanobiotechnology in drug discovery. In, Guzman CA and Feuerstein G (eds) Pharmaceutical Biotechnology.  Landes Press, Austin, Texas, 2009. or Adv Exp Med Biol 2009;655:37-43.</li>	
			<li>Nanomedicine: application of nanobiotechnology in medical practice. Medical Principles &amp; Practice 2008;17:89-101.</li>
			<li>Cancer Biomarkers: current issues and future directions. Curr Opin Mol Ther 2007;9:563-71.</li>
			<li>Applications of Nanobiotechnology in Clinical Diagnostics.Clin Chem 2007;53:2002-2009.</li>
			<li>Recent advances in clinical oncoproteomics. Journal of BUON 2007;12 (suppl 1):S31-S38.</li>
			<li>Drug delivery systems: an overview. In, Jain KK (ed). Drug Delivery Systems. Totowa, NJ, Humana Press, 2008:1-50.</li>
			<li>Nanotechnology in drug discovery. In, Seethala R (ed) Handbook of Drug Screening, 2nd edition, Informa, 2009:464-475.</li>
			<li>How Will Genomics Affect the Practice of Neurology? <a href="http://bmctoday.net/practicaldermatology/">Practical Neurology</a> 2007;6:44-51.</li>
			<li>Recent advances in nanooncology. TCRT 2008;7:1-13.</li>
			<li>Pain Management: Visiongain Fourth Annual Conference, 31 October to 2 November 2007, London UK. IDrugs 2008;11:27-29.</li>
			<li>Biotechnology-based Drug Discovery. In, Rapley R (ed) Molecular Biology and Biotechnology, 5th Edition, Royal Society of Chemistry, Cambridge, UK, 2008:307-336.</li>
			<li>Personalized Clinical Laboratory Diagnostics. Adv Clin Chem, 2008;47:95-119.</li>
			<li>Innovations, Challenges and Future prospects of Oncoproteomics. Molecular Oncology 2008;2:153-160.</li>				
			<li>Current challenges and future prospects in management of neuropathic pain. Expert Review of Neurotherapeutics 2008;;8:1735-1748.</li>
			<li>Gene therapy for pain. Expert Opinion on Biological Therapy. 2008;8:1855-1866.</li>
			<li>Cell therapy for pain. Expert Opinion on Biological Therapy. 2008;8:1847-1853.</li>
			<li>Neuroprotection in Traumatic Brain Injury. Drug Discovery Today 2008;13:1082-89.</li>
			<li>Role of nanobiotechnology in the development of personalized medicine. Nanomed 2009;4:249-52.</li>
			<li>Current Status and Future Prospects of Nanoneurology. J Nanoneuroscience 2009;1:56-64.</li>
			<li>Cell Therapy for CNS Trauma. Mol Biotechnol 2009;42:367-376.</li>
			<li>Application of Nanobiotechnology in Cancer Therapeutics. In, Lu Y, Mahato RI (eds) Pharmaceutical Perspectives of Cancer Therapeutics. Springer, New York, 2009:245-268.</li>
			<li>Potential of nanobiotechnology in management of glioblastoma multiforme. In, Ray SK (ed) Glioblastoma: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies, Springer, New York, 2010:399-419.</li>
			<li>Novel strategies for the treatment of brain cancer. In, Erdmann VA, Reifenberger G, Barciszewski J (eds) Therapeutic Ribonucleic Acids in Brain Tumors, Springer, Heidelberg, 2009:85-102.</li>
			<li>An overview of drug delivery to the central nervous system. Neuromethods 2010;45:DOI 10.1007/978-1-60761-529-3_1.</li>
			<li>Innovative diagnostic technologies and their significance for personalized medicine. 2010 Mol Diagn Ther;14:141-7.</li>
			<li>Personalized cancer vaccines. Expert Opin Biol Ther 2010;12:1637-47.</li>
			<li>Integration of biotechnologies for the development of personalized medicine. In, Kayser O and Warzecha H (eds) Pharmaceutical Biotechnology, 2nd ed, John Wiley &amp; Sons, 2010.</li>	
			<li>Recent advances in nanooncology. BMC Medicine 2010;8:83.</li>
			<li>The Role of Nanobiotechnology in the Development of Personalized Medicine (commentary). Med Princ Pract 2011;20:1-3.</li>
			<li>Role of Nanobiotechnology in the Personalized Management of Glioblastoma Multiforme. Nanomedicine 2011;6:411-4.</li>
			<li>Nanobiotechnology and Personalized Medicine. Prog Mol Biol Transl Sci 2011;104:325-54.</li>
			<li>Role of nanodiagnostics in personalized cancer therapy. Clin Lab Med 2012;32:15-31.</li>
			<li>Role of biological therapies in the development of personalized medicine (invited editorial). Expert Opin Biol Ther 2012;12:1-5.</li>		     
			<li>Nanobiotechnology-based strategies for crossing the blood-brain barrier. Nanomedicine 2012;7:1225-33.</li>
			<li>Advances in functionalized carbon nanotubes in drug design and discovery. Expert Opin Drug Discov 2012;7:1029-37.</li>
			<li>Synthetic biology and personalized medicine. Medical Principles &amp; Practice, 2013;22:209-19.</li>			
			<li>Proteomics: Pharmaceutical Applications. In, Swarbrick J (ed) Encyclopedia of Pharmaceutical Science and Technology, 4th ed, 2013, Informa Healthcare</li>			
			<li>Current status and future prospects of drug delivery systems. Methods Mol Biol 2014;1141:1-56.</li>
			<li>An Overview of methods used in neurogenomics and their applications. In, Jain KK (ed) Applied Neurogenomics, Humana/Springer, 2015.</li>
			<li>Role of neurogenomics in the development of personalized neurology. In, Jain KK (ed) Applied Neurogenomics, Humana/Springer, 2015.</li>
			<li>Future of nanomedicine: impact on healthcare & society. Nanomedicine (Lond) 2015;10:3199-202.</li>
			<li>Nanomedicine book review. Nanomedicine (Lond) 2015;10:3325-7.</li>
			<li>Regenerative Therapy for Central Nervous System Trauma. In, Steinhoff G (ed) Regenerative Medicine: from protocol to patient, 3rd ed, Vol 4. Springer International, Switzerland, 2016:115-45.</li>
            <li>Personalized management of cardiovascular disorders. Medical Principles &amp; Practice, 2018;26:399-414.</li>
            <li>A Critical Overview of Targeted Therapies for Glioblastoma. Front Oncol 2018;8:419.</li>
            <li>Nanobiotechnology. Chapter 68 in, Butler M (ed) Scientific Fundamentals in Biotechnology, 3rd edn, Vol 1, Section 6: The biophysical basis. Elsevier, Amsterdam, 2021.</li
           	<li>Personalized immuno-oncology. Medical Principles &amp; Practice, 2021;30(1):1-16.</li>	
           			
			</ol>
			
			<h2><a name="2">Contributions to MedLink Neurology</a></h2>
			
			<p><a href="http://www.medlink.com/">MedLink Corporation</a>,
			San Diego, California, USA. 1997-current. The 169 articles are part
			of an electronic encyclopedia of neurology containing 1450 articles by approximately 450 authors, which are updated once a year.</p>
			
			<h3>Neuropharmacology</h3>
			
			<ol>
				<li>Principles of neuropharmacology</li>
				<li>Clinical trials and drug development for neurological disorders</li>
				<li>Statistics for the neurologists</li>
				<li>Drug delivery to the central nervous system</li>
				<li>Blood-Brain Barrier</li>
				<li>Innovative therapies for cerebral vasospasm</li>
				<li>Ion channels and neurological disorders</li>
				<li>Chelation therapy in neurological disorders</li>
				<li>Vaccination for neurological disorders</li>
				<li>Intrathecal therapy</li>
			</ol>
			
			<h3>Drugs used for neurological disorders</h3>
			
			<ol start="11">
				<li>Alentuzumab</li>
				<li>Alteplase</li>
				<li>Anticholinergics</li>
				<li>Anticonvulsants</li>
				<li>Antipsychotics</li>
				<li>Atomoxetine</li>
				<li>Azathioprine</li>
				<li>Baclofen</li>
				<li>Benzodiazepines</li>
				<li>Carbamazepine</li>
				<li>Citalopram</li>
				<li>Clopidogrel</li>
				<li>Coenzyme Q10</li>
				<li>Dalfampridine</li>
				<li>Dihydroergotamine</li>
				<li>Dimethyl fumarate</li>
				<li>Diazepam</li>
				<li>Donepezil</li>
				<li>Duloxetine</li>
				<li>Edaravone</li>
				<li>Entacapone</li>
				<li>Eteplirsen</li>
				<li>Fingolimod</li>
				<li>Fluoxetine</li>
				<li>Fosphenytoin</li>
				<li>Gabapentin</li>
				<li>Galantamine</li>
				<li>Glatiramer</li>
				<li>Infliximab</li>
				<li>Interferon beta 1a</li>
				<li>Interferon beta 1b</li>				
				<li>Intravenous immune globulin</li>
				<li>Lacosamide</li>
				<li>Lamotrigine</li>
				<li>Levetiracetam</li>
				<li>Levodopa</li>
				<li>Memantine</li>
				<li>Methylphenidate</li>
				<li>Mitoxantrone</li>
				<li>Mycophenolate</li>
				<li>Modafinil</li>
				<li>Monoclonal antibodies for migraine prophylaxis</li>
				<li>Natalizumab</li>
				<li>Nimodipine</li>
				<li>Nusinersen</li>						
				<li>Oxcarbazepine</li>				
				<li>Perampanel</li>
				<li>Phenytoin</li>
				<li>Pramipexole</li>
				<li>Prednisone</li>
				<li>Pregabalin</li>
				<li>Primidone</li>
				<li>Propofol</li>
				<li>Pyridostigmine</li>
				<li>Rasagiline</li>
				<li>Resperidone</li>
				<li>Riluzole</li>
				<li>Rivastigmine</li>
				<li>Ropinirole</li>
				<li>Rotigotine</li>
				<li>Selective Serotonin Reuptake Inhibitors</li>
				<li>Selegeline</li>
				<li>Sodium oxybate</li>
				<li>Sumatriptan</li>
				<li>Tapentadol </li>
				<li>Tiagabine</li>
				<li>Tizanidine</li>
				<li>Tolcapone</li>
				<li>Topiramate</li>
				<li>Triptans</li>
				<li>Valproic acid</li>
				<li>Vigabatrin</li>
				<li>Ziconotide</li>
				<li>Zonisamide</li>
			</ol>
			
			<h3>Neuroprotection, neurotrophic factors and regenerative neurology</h3>
			
			<ol start="88">
				<li>Neuroprotection in disorders of the central nervous system</li>
				<li>Principles of regeneration and repair in the nervous system</li>
				<li>Cell therapy for neural repair and regeneration</li>
				<li>Scientific basis of the application of neurotrophic factors in neurological disorders</li>
				<li>Application of neurotrophic factors in degenerative neurological disorders</li>
				<li>Application of neurotrophic factors in peripheral neuropathies</li>
				<li>Application of neurotrophic factors in cerebrovascular disorders</li>
				<li>Application of neurotrophic factors in trauma to the nervous system</li>
			</ol>
			
			<h3>Gene therapy</h3>
			
			<ol start="96">
				<li>Gene therapy for neurological disorders: methods and principles</li>
				<li>Gene therapy of neurogenetic disorders</li>
				<li>Gene therapy of malignant gliomas</li>
				<li>Gene therapy of neurodegenerative disorders</li>
				<li>Gene therapy of muscular dystrophy</li>
				<li>Gene therapy of cerebrovascular disease</li>
			</ol>
			
			<h3>Pharmacotherapy of pain</h3>
			
			<ol start="102">
				<li>Overview, physiology, and approach to the management of pain</li>
				<li>Pathophysiology and management of chronic pain</li>
				<li>Pathophysiology and management of cancer pain</li>
				<li>Central neuropathic pain: pathophysiology and pharmacotherapy</li>
				<li>Phantom limb pain</li>
				<li>Myofascial pain syndrome</li>
				<li>Fibromyalgia</li>
			</ol>
			
			<h3>Drug-induced Neurological Disorders</h3>
			
			<ol start="109">
				<li>Introduction to drug-induced neurological disorders</li>
				<li>Drug-induced aseptic meningitis</li>
				<li>Drug-induced cerebrovascular disorders</li>
				<li>Drug-induced delirium</li>
				<li>Drug-induced dementia</li>
				<li>Drug-induced disturbances of taste and smell</li>
				<li>Drug-induced memory disorders</li>
				<li>Drug-induced myopathy</li>
				<li>Drug-induced seizures</li>
				<li>Drug-induced syncope</li>
				<li>Neurological complications of general anesthesia</li>
				<li>Neurological complications of local anesthesia</li>
				<li>Serotonin syndrome</li>
				<li>Stupor and coma due to drug intoxication</li>
			</ol>
			
			<h3>Sleep disorders</h3>
			
			<ol start="123">
			<li>Drug-induced insomnia and excessive daytime sleepiness</li>
			<li>Drug-induced parasomnias, sleep apnea, and restless legs syndrome</li>
			<li>Stimulant-dependent sleep disorder</li>
			<li>Nightmares</li>
			<li>Insufficient sleep syndrome</li>
			<li>Sleep and intellectual disability</li>
			<li>Insomnia</li>
			
			</ol>			
				
			<h3>Alternative therapies in neurology</h3>
			
			<ol start="130">
				<li>Alternative methods for the treatment of neurological disorders</li>
				<li>Acupuncture and the neurologist</li>
				<li>Neurological complications of chiropractic manipulations</li>
				<li>Transcranial magnetic stimulation</li>
				<li>Hyperbaric oxygenation for treatment of stroke.</li>
			</ol>
			
			<h3>Molecular diagnostics</h3>
			
			<ol start="135">
				<li>Principles and methods of molecular diagnostics of neurologic disorders</li>
				<li>Molecular diagnosis of CNS malignancies</li>
				<li>Molecular diagnosis of infections of the CNS</li>
				<li>Molecular diagnosis of neurogenetic disorders</li>
			</ol>
			
			<h3>Neurogastroenterology</h3>
			
			<ol start="139">
				<li>Introduction to neurogastroenterology</li>
				<li>Neurological aspects of nausea and vomiting</li>
				<li>Dysphagia</li>
			</ol>
			
			<h3>Neurological disorders caused by changes in environments</h3>
			
			<ol start="142">
				<li>High pressure neurological syndrome</li>
				<li>Mountain sickness</li>
				<li>Carbon monoxide poisoning</li>
				<li>Neurologic complications of decompression</li>
				<li>Heat stroke</li>
			</ol>
			
			<h3>Applications of biotechnology in neurology</h3>
			
			<ol start="147">
				<li>Personalized neurology</li>
				<li>Applied neurogenomics</li>
				<li>Biomarkers in neurology</li>
				<li>Digital neurology</li>
				<li>Neuroproteomics</li>
				<li>Neuromodulation</li>
				<li>Integration of diagnostics and therapeutics in the practice of neurology</li>
				
			</ol>	
			
			<h3>Miscellaneous topics in neurology, neurological syndromes</h3>
			
			<ol start="154">
				<li>Neurology of aging</li>				
				<li>Nutrition and the brain</li>
				<li>Vitamin E and neurological disorders</li>
				<li>Hepatic encephalopathy</li>
				<li>Multiple cranial nerve palsies</li>
				<li>Susac Syndrome</li>
				<li>Turcot syndrome</li>
				<li>Hiccup: Pathomechanisms and management</li>				
				<li>Gulf war syndrome</li>				
				<li>Neurological aspects of chemical and biological warfare agents</li>
				<li>Neurological aspects of pathological laughter</li>
				<li>Neurological causes and complications of fever</li>
				<li>Dysathria</li>
				<li>Neurological aspects of excessive yawning</li>
				<li>Electrical injuries: neurological aspects</li>
				<li>Medical errors</li>
				<li>Cerebral edema</li>
				<li>Role of neuroinflammation in pathogenesis of neurological disorders and principles of management</li>
				<li>Preoperative preparation of the neurological patient</li>
				
			</ol>
			
			<h2><a name="3">Books</a></h2>
			
			<ol>
				<li>Health Care in New China. Rodale Press, Emmaus, Pennsylvania, 1973.</li>
				<li>Handbook of Laser Neurosurgery. Charles C. Thomas, Springfield, Illinois, 1983.</li>
				<li>Handbook of Hyperbaric Oxygen Therapy. Springer-Verlag, New York, 1988.</li>
				<li>Oxygen in Physiology and Medicine. Charles C. Thomas, Springfield, 1989.</li>
				<li>Carbon Monoxide Poisoning, Warren H. Green, St. Louis, Missouri, 1990.</li>
				<li>Cerebral Insufficiency - pathophysiology and management. Year Book Publishers, Chicago, 1990.</li>
				<li>Textbook of Hyperbaric Medicine. <a href="http://www.hhpub.com/">Hogrefe &amp; Huber</a>, Goettingen, Germany, 5th edition, 2009.Croatian ed, 2012</li>
				<li><a name="b08" href="http://www.amazon.com/exec/obidos/ASIN/0889372195/jainpharmabiotec">Drug-induced Neurological Disorders</a>. <a href="http://www.hhpub.com/">Hogrefe &amp; Huber</a>, Goettingen, Germany, 3rd ed 2011.</li>
				<li><a name="b09" href="http://www.amazon.com/exec/obidos/ASIN/0889371903/jainpharmabiotec">Textbook of Gene Therapy</a>, <a href="http://www.hhpub.com/">Hogrefe &amp; Huber</a>, Goettingen, Germany, 1998 (Chinese edition 2000).</li>
				<li><a name="b09" href="http://www.amazon.com/exec/obidos/ASIN/0471492906/jainpharmabiotec">Gene Therapy Companies</a>, John Wiley &amp; Sons, Chicester, UK, 2000 (updated version is included in the report on gene therapy 2013)</li>
				<li>Nanobiotechnology in Molecular Diagnostics. Horizon Scientific Press, Norwich, UK, 2006 </li>
				<li>Jain KK (ed) Drug Delivery Systems.<a href="http://www.springer.com/humana+press/biotechnology/book/978-1-58829-891-1">Humana/Springer</a>, Totowa, NJ, 2008 </li>
				<li>Handbook of Nanomedicine. <a href="http://www.springer.com/humana+press/biotechnology/book/978-1-60327-318-3">Humana/Springer</a>,Totowa, NJ, 2008 (translated for Chinese Edition, Peking University Press 2011). </li>
				<li>Textbook of Personalized Medicine. <a href="http://www.springer.com/new+%26+forthcoming+titles+(default)/book/978-1-4419-0768-4">Springer</a>, New York 2009, Japanese edition, International Society of Integrative Medicine 2012. </li>
				<li>Jain KK (ed) Drug Delivery to the Central Nervous System. <a href=" http://dx.doi.org/10.1007/978-1-60761-529-3">Humana/Springer</a>, Totowa, NJ, Jan 2010</li>
				<li>The Handbook of Biomarkers. <a href="http://www.springer.com/biomed/pharmaceutical+science/book/978-1-60761-684-9">Springer</a>,New York, 2010 (translated for Chinese edition, Chemical Industry Press, due 2016) </li>
				<li>The Handbook of Neuroprotection. <a href="http://www.springer.com/biomed/neuroscience/book/978-1-61779-048-5">Springer</a>, 2011.</li>
				<li>Application of Biotechnology in Cardiovascular Therapeutics. <a href="http://www.springer.com/chemistry/biotechnology/book/978-1-61779-239-7">Springer</a>, New York, 2011.</li>				
				<li>Jain KK (ed) Nanooncology. Clinics Lab Med, Elsevier, 2012.  </li> 
				<li>Handbook of Nanomedicine, 2nd ed. <a href="http://dx.doi.org/10.1007/978-1-61779-983-9">Springer</a>, New York, 2012. </li>
				<li>Applications of Biotechnology in Neurology. <a href="http://www.springer.com/biomed/neuroscience/book/978-1-62703-271-1">Springer</a>, New York, 2013. </li>
				<li>Applications of Biotechnology in Oncology. <a href="http://link.springer.com/book/10.1007%2F978-1-4614-9245-0">Springer</a>, New York, 2014. </li>
				<li>Jain KK (ed) Drug Delivery Systems. 2nd ed. <a href="http://www.springer.com/chemistry/biotechnology/book/978-1-4939-0362-7">Springer</a>, New York, 2014. </li>	
				<li>Jain KK (ed) Applied Neurogenomics. Humana/Springer, New York, 2015. </li>	
				<li>Textbook of Personalized Medicine, 2nd ed. <a href="http://link.springer.com/book/10.1007%2F978-1-4939-2553-7">Humana/Springer</a>, New York, 2015. </li>
				<li>Textbook of Hyperbaric Medicine, 6th ed. <a href=" http://www.springer.com/us/book/9783319471389">Springer</a>, Cham, Switzerland, 2017. </li>
				<li>A Handbook of Nanomedicine, 3rd ed. <a href="http://www.springer.com/gp/book/9781493969654">Springer</a>, New York, 2018.</li>
				<li>A Handbook of Biomarkers, 2nd ed. <a href="http://www.springer.com/gp/book/9781493974306">Springer</a>, Springer, New York, 2018.</li>
				<li>A Handbook of Neuroprotection, 2nd ed (rewritten).<a href="https://www.springer.com/us/book/9781493994649"> Springer</a>, New York, 2019. </li>
				<li>Jain KK (ed) Drug Delivery Systems, 3rd ed (new techniques). Springer, New York, 2019. </li>
				<li>Jain KK, Sharapov K. Essentials of Personalized Medicine (in Russian), Geotar-Media, Moscow, Russia, 2019. </li>
				<li>Textbook of Personalized Medicine, 3rd ed. <a href="https://www.springer.com/us/book/9783030620790">Springer</a>, Cham, 2021. </li>
				<li>Drug-induced Neurological Disorders, 4th ed. <a href="https://link.springer.com/book/10.1007/978-3-030-73503-6#authorsandaffiliationsbook">Springer</a>, Cham (Switzerland), 2021. </li>
				<li>A Handbook of Alzheimer disease. Springer, Cham (Switzerland), 2022 (in preparation). </li>
				
			</ol>
			
			<h2><a name="4">Reports</a></h2>
			
			<h3>Published by PJB Publications, Richmond, UK</h3>
			
			<ol>
				<li>Clinica Report on DNA Diagnostics, 1995.</li>
				<li>Scrip Report on Gene Therapy, 1995.</li>
				<li>Scrip Report on Ion Channels, 1995.</li>
				<li>Scrip Report on Vectors for Gene Therapy, 1996.</li>
				<li>Scrip Report on Antisense Therapy, 1996.</li>
				<li>Scrip Report on Cancer Gene Therapy, 1996.</li>
			</ol>
			
			<h3>Published by Decision Resources, Waltham, MA, USA</h3>
			
			<ol start="7">
				<li>Cognos Report on Parkinson's Disease, 1996.</li>
				<li>Gene Therapy of Neurological Disorders, 1997.</li>
				<li><a name="r09">Molecular Diagnostics</a>, 1997.</li>
				<li>Personalized Medicines: The impact of pharmacogenetics on drug development, 1998.</li>
				<li>Drug Delivery Systems, 1998.</li>
				<li>Impact of Genomics on Drug Discovery and Development, 1999.</li>
				<li>Commercial Opportunities in Serotonin Modulating Drugs, 1999.</li>
				<li>Molecular Diagnostics II, 1999.</li>
				<li>Drug Delivery in CNS Diseases: Technologies and commercial opportunities, March 2000.</li>
				<li>Drug Delivery in Cancer: technologies and commercial opportunities, June 2000.</li>
			</ol>
			
			<h3>Published by International Business Communications (IBC)</h3>
			
			<ol start="17">
				<li>Jain KK (Ed), Proceedings of the Conference 'Gene to Screen', IBC, London, 1996.</li>
				<li>Strategies for Success in Biotechnology. D&amp;MD Division, IBC, Southborough, Massachusetts, 1997.</li>
				<li>Stroke. D&amp;MD, Division, IBC, Southborough, Massachusetts, 1998.</li>
			</ol>
			
			<h3>Published by Informa Global Pharmaceuticals &amp; Healthcare, London.</h3>
			
			<ol start="20">
				<li>Drug Delivery Technologies. 2000.</li>
				<li>Biochips. 2000.</li>
				<li>Drug Discovery: current trends and future prospects. 2001.</li>
				<li>Ageing: biology, healthcare and pharmaceutical opportunities. 2001.</li>
				<li>Personalized Medicine. 2001.</li>
			</ol>
			
			<h3>Miscellaneous Publishers</h3>
			
			<ol start="25">
				<li>Jain KK, Tool JF (Eds) Hyperacute Hyperbaric Oxygen Therapy for Stroke: Proceedings of a Conference held at Bowman Gray School of Medicine, Winston-Salem, North Carolina, 2-4 Nov 1997. Undersea &amp; Hyperbaric Medical Society of the USA, Bethesda, Maryland, 1998.</li>
				<li>Antisense Technologies: commercial opportunities, <a href="http://www.reutersbusinessinsight.com/">Reuters Business Insight</a>, UK, 2000.</li>
				<li>Pain therapeutics: re-evaluation of strategies, <a href="http://www.reutersbusinessinsight.com/">Reuters Business Insight</a>, UK, 2000.</li>
			</ol>
			
			<h3>Published by <a href="/">Jain PharmaBiotech</a>, Basel, Switzerland.</h3>
			
			<ol start="28">
				<li><a href="/reports/ntf/">Neurotrophic Factors - Current Status and Future Potential</a>. Published in 1996. Revised 2000.</li>
				<li><a href="/reports/np/">Neuroprotection - Drugs, Companies and Markets</a>. 2021.</li>
				<li><a href="/reports/proteomics/">Proteomics - Technologies, Companies and Markets</a>. 2021.</li>
				<li><a href="/reports/celltherapy/">Cell Therapy - Technologies, Companies and Markets</a>. 2021.</li>
				<li><a href="/reports/mdx/">Molecular diagnostics - Technologies, Companies and Markets</a>. 2021.</li>
				<li><a href="/reports/td/">Transdermal Drug Delivery - Technologies, Companies and Markets</a>. 2021.</li>
				<li><a href="/reports/animalbiotech/">Animal Biotechnology - Technologies, Companies and Markets</a>.  2021.</li>
				<li><a href="/reports/pain/">Pain Therapeutics - drugs, companies and markets</a>. 2021.</li>
				<li><a href="/reports/persmed/">Personalized Medicine - scientific and commercial aspects</a>. 2021.</li>
				<li><a href="/reports/nitox/">Nitric Oxide - therapeutics, markets and companies</a>. 2021.</li>
				<li><a href="/reports/ad/">Alzheimer disease - new drugs, markets and companies</a>. 2021.</li>
				<li><a href="/reports/cancer/">Drug Delivery in Cancer - technologies, markets and companies</a>. 2021.</li>
				<li><a href="/reports/rnai/">RNAi - technologies, markets and companies</a>. 2021.</li>
				<li><a href="/reports/genetherapy/">Gene Therapy - technologies, markets and companies</a>. 2021.</li>
				<li><a href="/reports/nanobiotechnology/">Nanobiotechnology - applications, markets and companies</a>. 2021.</li>
				<li><a href="/reports/cns/">Drug Delivery in Central Nervous System Disorders - technologies, markets and companies</a>. 2021.</li>
				<li><a href="/reports/cardiovascular/">Cardiovascular Drug Delivery - technologies, markets and companies</a>. 2021.</li>
				<li><a href="/reports/biomarkers/">Biomarkers - technologies, markets and companies</a>. 2021.</li>
				<li><a href="/reports/cytogenetics/">Cytogenetics - technologies, markets and companies</a>. 2021.</li>
				<li><a href="/reports/antiviral/">Antiviral Therapeutics - technologies, markets and companies</a>. 2021.</li>
				<li><a href="/reports/sequencing/">DNA Sequencing - technologies, markets and companies</a>. 2021.</li>
				<li><a href="/reports/biochips/">Biochips/Microarrays - technologies, markets and companies</a>. 2021.</li>
				<li><a href="/reports/tdm/">Therapeutic Drug Monitoring - technologies, markets and companies</a>. 2021.</li>
			</ol>
		</div>
		
		<div id="footer">
			&copy; 2021 Jain PharmaBiotech. All Rights Reserved. 
		</div>
		
	</body>
</html>
